• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阵发性睡眠性血红蛋白尿症(PNH)克隆何时具有临床意义?

When does a PNH clone have clinical significance?

机构信息

Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA; and Comprehensive Bone Marrow Failure Center, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.

出版信息

Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):143-152. doi: 10.1182/hematology.2021000245.

DOI:10.1182/hematology.2021000245
PMID:34889408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8791108/
Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired blood disease caused by somatic mutations in the phosphatidylinositol glycan class A (PIGA) gene required to produce glycophosphatidyl inositol (GPI) anchors. Although PNH cells are readily identified by flow cytometry due to their deficiency of GPI-anchored proteins, the assessment of the clinical significance of a PNH clone is more nuanced. The interpretation of results requires an understanding of PNH pathogenesis and its relationship to immune-mediated bone marrow failure. Only about one-third of patients with PNH clones have classical PNH disease with overt hemolysis, its associated symptoms, and the highly prothrombotic state characteristic of PNH. Patients with classical PNH benefit the most from complement inhibitors. In contrast, two-thirds of PNH clones occur in patients whose clinical presentation is that of bone marrow failure with few, if any, PNH-related symptoms. The clinical presentations are closely associated with PNH clone size. Although exceptions occur, bone marrow failure patients usually have smaller, subclinical PNH clones. This review addresses the common scenarios that arise in evaluating the clinical significance of PNH clones and provides practical guidelines for approaching a patient with a positive PNH result.

摘要

阵发性睡眠性血红蛋白尿症(PNH)是一种后天获得性血液疾病,由磷脂酰肌醇聚糖 A(PIGA)基因的体细胞突变引起,该基因对于产生糖基磷脂酰肌醇(GPI)锚定物是必需的。虽然 PNH 细胞由于缺乏 GPI 锚定蛋白,很容易通过流式细胞术来识别,但评估 PNH 克隆的临床意义更为复杂。结果的解释需要了解 PNH 的发病机制及其与免疫介导的骨髓衰竭的关系。只有大约三分之一的 PNH 克隆患者患有典型的 PNH 疾病,表现为明显的溶血、相关症状以及 PNH 特有的高度血栓形成状态。典型 PNH 患者从补体抑制剂中获益最多。相比之下,三分之二的 PNH 克隆发生在表现为骨髓衰竭且仅有少数(如果有的话)与 PNH 相关的症状的患者中。临床表现与 PNH 克隆大小密切相关。尽管存在例外情况,但骨髓衰竭患者通常具有较小的、亚临床的 PNH 克隆。这篇综述讨论了在评估 PNH 克隆的临床意义时出现的常见情况,并为处理 PNH 阳性结果的患者提供了实用的指导方针。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85de/8791108/5276b3eb2abc/hem.2021000245_s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85de/8791108/5276b3eb2abc/hem.2021000245_s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85de/8791108/5276b3eb2abc/hem.2021000245_s1.jpg

相似文献

1
When does a PNH clone have clinical significance?阵发性睡眠性血红蛋白尿症(PNH)克隆何时具有临床意义?
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):143-152. doi: 10.1182/hematology.2021000245.
2
Paroxysmal nocturnal hemoglobinuria in children.儿童阵发性夜间血红蛋白尿症
Paediatr Drugs. 2007;9(1):11-6. doi: 10.2165/00148581-200709010-00002.
3
A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.再生障碍性贫血患者阵发性夜间血红蛋白尿克隆性质及PIG-A突变的队列研究。
Eur J Haematol. 2006 Jun;76(6):502-9. doi: 10.1111/j.0902-4441.2005.t01-1-EJH2467.x. Epub 2006 Mar 9.
4
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 1 - clinical utility.ICCS/ESCCA 共识指南:检测阵发性睡眠性血红蛋白尿症(PNH)及相关疾病中 GPI 缺陷细胞——临床应用。
Cytometry B Clin Cytom. 2018 Jan;94(1):16-22. doi: 10.1002/cyto.b.21608.
5
[Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].[阵发性夜间血红蛋白尿(PNH)。发病机制、诊断与治疗]
Dtsch Med Wochenschr. 2009 Feb;134(9):404-9. doi: 10.1055/s-0028-1124013. Epub 2009 Feb 17.
6
A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿分子发病机制的一个新方面。
Hematology. 2002 Aug;7(4):211-27. doi: 10.1080/1024533021000024094.
7
Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.阵发性夜间血红蛋白尿症与补体系统:最新见解与新型抗补体策略。
Adv Exp Med Biol. 2013;735:155-72. doi: 10.1007/978-1-4614-4118-2_10.
8
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.阵发性睡眠性血红蛋白尿症(PNH)患者的基线临床特征和疾病负担:国际 PNH 登记处的更新分析。
Ann Hematol. 2020 Jul;99(7):1505-1514. doi: 10.1007/s00277-020-04052-z. Epub 2020 May 10.
9
New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症骨髓衰竭分子发病机制的新见解
Int J Hematol. 2007 Jul;86(1):27-32. doi: 10.1532/IJH97.07029.
10
Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.比较高敏流式细胞术与常规流式细胞术在诊断显性阵发性睡眠性血红蛋白尿症和检测微小阵发性睡眠性血红蛋白尿症克隆中的应用。
Ann Lab Med. 2019 Mar;39(2):150-157. doi: 10.3343/alm.2019.39.2.150.

引用本文的文献

1
Patient-Reported Meaningful Change in Symptoms and Impacts of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Three Phase III Clinical Trials of Iptacopan.在依他库帕的三项III期临床试验中患者报告的阵发性夜间血红蛋白尿(PNH)症状及影响的有意义变化
Patient. 2025 Jul 22. doi: 10.1007/s40271-025-00755-5.
2
The incidence of paroxysmal nocturnal hemoglobinuria cell clones in the Nordic countries.北欧国家阵发性夜间血红蛋白尿细胞克隆的发病率。
Ann Hematol. 2025 Jul 9. doi: 10.1007/s00277-025-06450-7.
3
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment.

本文引用的文献

1
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.阵发性夜间血红蛋白尿(PNH)患者血栓栓塞事件的危险因素:国际PNH注册研究中的一项巢式病例对照研究
Ann Hematol. 2023 Nov;102(11):2979-2988. doi: 10.1007/s00277-023-05402-3. Epub 2023 Sep 5.
2
The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.阵发性睡眠性血红蛋白尿(PNH)克隆、6号染色体短臂杂合性缺失(6p CN-LOH)及克隆性T细胞受体(TCR)基因重排在再生障碍性贫血诊断中的预测价值。
Blood Adv. 2021 Aug 24;5(16):3216-3226. doi: 10.1182/bloodadvances.2021004201.
3
阵发性夜间血红蛋白尿治疗的进展态势
Turk J Haematol. 2025 May 22;42(2):74-81. doi: 10.4274/tjh.galenos.2025.2025.0054. Epub 2025 Apr 21.
4
[Practice-oriented rational assessment of anemia].[以实践为导向的贫血合理评估]
Inn Med (Heidelb). 2025 May;66(5):485-496. doi: 10.1007/s00108-025-01880-x. Epub 2025 Apr 3.
5
Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症患者造血细胞移植的现状与展望
Front Immunol. 2025 Jan 7;15:1521484. doi: 10.3389/fimmu.2024.1521484. eCollection 2024.
6
[Interpretation of the guidelines for diagnosing and treating paroxysmal nocturnal hemoglobinuria in China (2024)].[《中国阵发性睡眠性血红蛋白尿诊断与治疗指南(2024年版)》解读]
Zhonghua Xue Ye Xue Za Zhi. 2024 Dec 14;45(12):1071-1077. doi: 10.3760/cma.j.issn.0253-2727.2024.12.101.
7
Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.亚洲再生障碍性贫血患者阵发性睡眠性血红蛋白尿症的监测和治疗:专家共识。
Int J Mol Sci. 2024 Nov 13;25(22):12160. doi: 10.3390/ijms252212160.
8
Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment.阵发性睡眠性血红蛋白尿症(PNH)中的血栓形成:从发病机制到治疗。
Int J Mol Sci. 2024 Nov 11;25(22):12104. doi: 10.3390/ijms252212104.
9
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy- a report of two cases.妊娠期阵发性夜间血红蛋白尿伴轻度溶血的管理——两例报告
Ann Hematol. 2025 Feb;104(2):1249-1253. doi: 10.1007/s00277-024-06086-z. Epub 2024 Nov 13.
10
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment.阵发性夜间血红蛋白尿症、病理生理学、诊断与治疗
Transfus Med Hemother. 2024 Aug 21;51(5):310-320. doi: 10.1159/000540474. eCollection 2024 Oct.
Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
在获得性再生障碍性贫血患者中,缺乏 HLA 的造血干细胞祖细胞与缺乏 GPI 锚定蛋白的造血干细胞祖细胞在分级阶段和对免疫攻击的敏感性上存在差异。
Leukemia. 2021 Nov;35(11):3257-3267. doi: 10.1038/s41375-021-01202-8. Epub 2021 Apr 6.
4
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.佩格司他单抗与依库珠单抗治疗阵发性睡眠性血红蛋白尿症的疗效比较。
N Engl J Med. 2021 Mar 18;384(11):1028-1037. doi: 10.1056/NEJMoa2029073.
5
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.骨髓增生异常综合征和再生障碍性贫血中小阵发性睡眠性血红蛋白尿克隆的临床和预后意义。
Leukemia. 2021 Nov;35(11):3223-3231. doi: 10.1038/s41375-021-01190-9. Epub 2021 Mar 4.
6
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.不同的遗传途径定义了 Shwachman-Diamond 综合征中恶性前与代偿性克隆性造血。
Nat Commun. 2021 Feb 26;12(1):1334. doi: 10.1038/s41467-021-21588-4.
7
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.阵发性睡眠性血红蛋白尿症中PIGA基因型对红细胞表型的影响
Leukemia. 2021 Aug;35(8):2431-2434. doi: 10.1038/s41375-020-01113-0. Epub 2021 Jan 22.
8
The predictive value of pre-treatment paroxysmal nocturnal hemoglobinuria clone on response to immunosuppressive therapy in patients with aplastic anemia: a meta-analysis.预处理阵发性睡眠性血红蛋白尿克隆对再生障碍性贫血患者免疫抑制治疗反应的预测价值:荟萃分析。
Hematology. 2020 Dec;25(1):464-472. doi: 10.1080/16078454.2020.1848083.
9
Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.阵发性睡眠性血红蛋白尿症(PNH)患者的预后因素和随访参数:奥地利 PNH 网络的经验。
Ann Hematol. 2020 Oct;99(10):2303-2313. doi: 10.1007/s00277-020-04214-z. Epub 2020 Aug 27.
10
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.获得性再生障碍性贫血和阵发性睡眠性血红蛋白尿症中的继发性骨髓增生异常综合征和白血病。
Blood. 2020 Jul 2;136(1):36-49. doi: 10.1182/blood.2019000940.